The differential diagnosis of the human dystrophinopathies and related disorders

Current Opinion in Neurology

Volumn 9, Issue 5, 1996, Pages 380-388

  Kakulas, Byron A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; UTROPHIN;

AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; BECKER MUSCULAR DYSTROPHY; DIFFERENTIAL DIAGNOSIS; DUCHENNE MUSCULAR DYSTROPHY; DYSTROPHY; GENE; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MUTATION; PHENOTYPE; REVIEW;

EID: 0029994173     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199610000-00012     Document Type: Review

References (73)

1. Hoffman EP: Clinical and histopathological features of abnormalities of the •• dystrophin-based membrane cytoskeleton. Brain Pathol 1996, 6:49-61. A definitive article bringing together Hoffman's many original discoveries. Clinical application is well considered of value to the neurologist.
2. Koenig M, Huffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM: Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organisation of the DMD gene in normal and affected Individuals. Cell 1987, 50:509-517.
3. Koenig M, Kunkel LM: Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. J Biol Chem 1990, 265:4560-4566.
4. Koenig M, Monaco AP, Kunkel LM: The complete sequence of dystrophin predicts a rod-shaped cytoskeleton protein. Cell 1988, 53:219-226.
5. Campbell K, Kahl S: Association of dystrophin and an integral membrane glycoprotein. Nature 1989, 122:809-823.
6. Brown Jr RH: Editorial review: dystrophin associated proteins and muscular • dystrophies: a glossary. Brain Pathol 1996, 6:19-24. A useful review of this group of cytoskeleton proteins and their clinical relevance.
7. Sadoulet-Puccio HM, Kunkel LM: Dystrophin and its isoforms. Brain Pathol 1996, 6:25-35.
8. Arahata K, Ishiura S, Ishiguro T, Tsukhara T, Suhara Y, Eguchi C, Ishihara T, Nonaka I, Ozawa E, Sugita H: Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature 1988, 333:861-863.
9. Bies RD, Phelps SF, Cortex MD, Roberts R, Caskey CT, Chamberlain JS: Human and murine dystrophin mRNA transcripts are differentially expressed during skeletal muscle, heart and brain development Nucleic Acids Res 1992, 20:1725-1731.
10. Bonilla E, Samitt CE, Miranda AF, Hays AP, Salviata G, Di Mauro S, Kunkel LM, Hoffman EP, Rowland LP: Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell 1988, 54:447-452.
11. Watkins SC, Huffman EP, Slayter HS, Kunkel LM: Immunoelectron microscopic localization of dystrophin in myofibres. Nature 1988, 333:863-866.
12. Zubrzycka-Gaarn EE, Bulman DE, Karpati G, Burghes AH, Beifall B, Klamut HJ, Talbot J, Hodges RS, Ray PN, Worton RG: The Duchenne muscular dystrophy gene product is localised in sarcolemma of human skeletal muscle. Nature 333:466-469.
13. Kakulas BA, Adams RO: Principles of myopathology as illustrated in the nutritional myopathy of the Rottnest Island quokka. Ann N Y Acad Sci 1966, 138:90-101.
14. Kakulas BA: Man, marsupials and muscle, Perth: University of Western Australia Press; 1982.
15. Kakulas BAS, Yu Pu G: Quantitative assessment of muscle lesions in 19 Duchenne necropsies [Abstract]. Muscle Nerve 1986, 9:206.
16. Kakulas BA, Cooper BJ: Experimental and animal models of human neuromuscular disease. In Disorders of voluntary muscle 6E. Edited by Walton JN, Karpati G, Hilton-Jones D. Edinburgh: Churchill Livingstone; 1995:437-497.
17. Howell JM, Kakulas BA, Pass DA, Genovese L, Rohnsen R, Lloyd F, Hobley WE: The fulminating neonatal form of expression in the golden retriever dog model of Duchenne muscular dystrophy [Abstract]. Muscle Nerve 1994, (suppl 1):S153.
18. Kakulas BA, McC Howell J, Roses AD: Duchenne muscular dystrophy: animal models and genetic manipulation. New York: Raven Press; 1992.
19. Blake DJ, Tinsley JM, Davies KE: Utrophin: a structural and functional comparison • to dystrophin. Brain Pathol 1996, 6:37-47. A useful review of this dystrophin analogue. Upregulation of utrophin is investigated as a form of gene therapy.
20. Hoffman EP: Genotype/phenotype correlations in Duchenne/Becker muscular dystrophy. In Molecular and cell biology of muscular dystrophy. Edited by PartridgeTA. London: Chapman & Hall; 1993:12-36.
21. Monaco ASP, Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM: An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 1988, 2:90-95.
22. Roberts RG, Barby TFM, Manner E, Bobrow M, Bentley DR: Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes. Am J Hum Genet 1991, 49:298-310.
23. Abbs S, Yau SC, Clark S, Mathew CG, Bobrow M: A convenient multiplex PCR system for the detection of dystrophin gene deletions: a comparative analysis with cDNA hybridization shows mistyping by both methods. J Med Genet 1991, 28:304-311.
24. Nicholson LVB, Johnson MA, Gardner-Medwin D, Battacharya S, Harris JB: Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy. Acta Neuropathologica 1990, 80:239-250.
25. Ioannou P, Christopoulos G, Panayides K, Kleanthous M, Middleton L: Detection of Duchenne and Becker muscular dystrophy carriers by quantitative multiplex polymerase chain reaction analysis. Neurology 1992, 42:1783-1790.
26. Roberts RG, Bentley RD, Barby TFM, Manners E, Bobrow M: Direct diagnosis of carriers of Duchenne and Becker muscular dystrophy by amplification of lymphocyte RNA. Lancet 1990, 336:1523-1526.
27. Laing NG, Mears ME, Thomas HE, Chandler DC, Layton MG, Goldblatt J, Kakulas BA: Differentiation of Becker muscular dystrophy from limb girdle muscular dystrophy and Kugelberg-Welander disease using cDNA probe. Med J Aust 1990, 152:270-271.
28. Lefebvre S, Burgien L, Reboullet S, Clermont O, Burlet P, Viollet L, Benichou B, • Cruaud C, Millasseau P, Zevianl M et al.: Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995, 80: 155-165. The definitive article on SMA gene localization. The gene was identified as the SMN gene.
29. Bradley WG, Jones MZ, Mussini JM, Fawcett PRW: Becker-type muscular dystrophy. Muscle Nerve 1978, 1:111-132.
30. Campbell K, Kahl S: Association of dystrophin and an Integral membrane glycoprotein. Nature 1989, 338:259-262.
31. Campbell KP: Three muscular dystrophies: loss of cytoskeleton-•• extracellular matrix linkage. Cell 1995, 80:675-679. A description of the role of the basement membrane in muscular dystrophy pathogenesis by a pioneer in the field.
32. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP: Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 1992, 355:696-702.
33. Yoshida M, Ozawa E: Glycoprotein complex anchoring dystrophin to sarcolemma. J Biochem 1990, 108:748-752.
34. Suzuki A, Yoshida M, Hayashi K, Mizuno Y, Hagiwara Y, Ozawa E: Molecular organization of the glycoprotein-complex-binding site of dystrophin. Eur J Biochem 1994, 220:283-292.
35. Tome F, Evagelista T, Leclerc A, Sunada Y, Manole E, Estournet B, Barios A, Campbell K, Fardeau M: Congenital muscular dystrophy with merosin deficiency. CR Acad Sci 1994, 317:351-357.
36. Senter L, Luise M, Presotto C, Betto R, Teresi KA, Ceoldo S, Salviata G: Interaction of dystrophin with cytoskeletan proteins: binding to talin and actin. Biochem Biophys Res Comm 1993, 192:899-904.
37. Dubowitz V (Editor): Neuromuscular disorders: gene location. Neuromusc Disord 1996, 6:I-IX.
38. Fadic R, Sunada Y, Waclawik AJ, Buck S, Lewandowski PJ, Campbell KP, Lotz BP: Brief report: deficiency of a dystrophin associated glycoprotein (adhalin) in a patient with muscular dystrophy and cardiomyopathy. New Eng J Med 1996, 334:362-366.
39. Speer MC, Yamoaka LH, Gilchrist JH, Gaskell CP, Stajich JM, Vance JM, Kazantsev A, Lastra AA, Haynes CS, Beckmann JS et al.: Confirmation of genetic heterogeneity in limb girdle muscular dystrophy: linkage of an autosomal dominant form to chromosome 5q. Am J Hum Genet 1992, 50:1211-1217.
40. Speer MC, Gilchrist JM, Chetkow JG, McMichael R, Westbrook CA, Stajich JM, • Jorgenson EM, Gaskell PC, Rosi BL, Ramesar R et al.: Evidence for locus heterogeneity in autosomal dominant limb girdle muscular dystrophy. Am J Hum Genet 1995, 57:1-6. A report of a variable LGMD phenotype.
41. Beckmann JS, Richard I, Hillaire D, Broux O, Antignao C, Bole E, Cann H, Cottingham RW, Feingold N, Feingold J et al.: A gene for limb-girdle muscular dystrophy maps to chromosome 15 by linkage. CR Acad Sci 1991, 312:141-148.
42. Sorimachi H, Toyama-Sorinmachi N, Saido TC, Kawasaki H, Sugita H, Miyaska M, Arahata KI, Ishiura S, Suzuki K.: Muscle-specific calpain, p94, is degraded by autolysis immediately after translation, resulting in disappearance from muscle. J Biol Chem 1993, 268:10593-10605.
43. Richard I, Broux O, Allamand V, Fougerousse F, Chiannllkulchai N, Bourg N, •• Brenguier L, Devaud C, Pasturaud P, Roudaut C et al.: Mutations of the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 1995, 81:27-40. A report of the discovery of the genetic basis of one of the common forms of LGMD. The identification of calcium activated protease three mutations as a cause of muscular dystrophy is a major step forward.
44. Kumamoto T, Ueyama H, Watanabe S, Yoshioka K, Miike T, Goll DE, Ando M, Tsuda T: Immunohistochemical study of calpain and its endogenous inhibitor in the skeletal muscle of muscular dystrophy. Acta Neuropathol 1995, 89:399-403.
45. Allamand V, Broux O, Bourg N, Richard I, Tischfield J, Hodes ME, Conneally PM, Fardeau M, Jackson CE, Beckmann JS: Genetic heterogeneity of autosomal recessive limb-girdle muscular dystrophy in a genetic isolate (Amish) and evidence for a new locus. Hum Mol Genet 1995, 4:469-484.
46. Allamand V, Broux O, Richard I, Fougerousse F, Chiannikulchai N, Bourg N, • Brenguier L, Devaud C, Pasturaud P, Pereira de Souza A et al.: Preferential localization of the limb-girdle muscular dystrophy type 2A gene in the proximal part of a 1-cM 15q15.1-q15.3 interval. Am J Hum Genet 1995, 56:1417-1430. A new genetic locus identified for LGMD.
47. Fardeau M, Hillaire D, Mignard C, Feingold N, Feingold J, Mignard D, •• de Ubeda B, Collin H, Tome FS, Richard I, Beckmann J: Juvenile limb-girdle muscular dystrophy. Clinical, histopathological and genetic data from a small community living in the Reunion Island Brain 1996, 119:295-308. A very informative paper bringing together a great deal of previous research by this group. This is the definitive description of the disorder.
48. Passos-Bueno MR, Bashir R, Moreira ES, Vainzof M, Marie SK, Vasquez L, lughetti P, Bakker E, Keers S, Stephenson A et al.: Confirmation of the 2p locus for the mild autosomal recessive limb girdle muscular dystrophy gene (LGMD2B) In three families allows refinement of the candidate region. Genomics 1995, 27:192-195.
49. Bashir R, Strachan T, Keers S, Stephenson A, Mahjneh I, Marconi G, Nashef L, Bushby KM: A gene for autosomal recessive limb-girdle muscular dystrophy maps to chromosome 2. Hum Mol Genet 1994, 3:455-457.
50. El Kerch F, Sefiani A, Azibi K, Boutaleb N, Yahyaoui M, Benthila A, Vinet MC, Leturcq F, Bachner L, Beckmann J et al.: Linkage analysis of families with severe childhood autosomal recessive muscular dystrophy in Morocco Indicates genetic homogeneity of the disease in North Africa. J Med Genet 1994, 31:342-343.
51. Ben Hamida M, Hamida CB, Zouari M, Belal S, Hentati F: Chromosome 13 linked muscular dystrophy [Abstract]. Neuromusc Disord 1996, 6:S8.
52. Jung D, Letureq F, Sunada Y, Duclos F, Tome FMS, Moomaw C, Merlini L, Azibi K, Chaouch M, Slaughter C et al.: Absence of y-sarcoglycan (35DAG) in autosomal recessive muscular dystrophy linked to chromosome 13q12. FEBS Lett 1996, 381:15-20.
53. Noguchi S, McNally EM, Othmane KB, Hagiwara Y, Mizuno Y, Yoshida M, Yamamoto H, Bonnemann CG, Gussoni E, Denton PH et al.: Mutations in the dystrophin association protein y-sarcoglycan in chromosome 13 muscular dystrophy. Science 1995, 270:819-822.
54. Matsumura K, Tome FMS, Collin H, Azibi K, Chaouch M, Kaplan JC, Fardeau M, Campbell KP: Deficiency of the 50k dystrophin-associated glycoprotein in severe childhood autosomal recessive muscular dystrophy. Nature 1992, 359:320-322.
55. Romero NB, Tome FMS, Leturco F, Kerch FE, Azibi K, Bachner L, Anderson RD, Roberds SL, Campbell KP, Fardeau M, Kaplan JC: Genetic heterogeneity of severe childhood autosomal recessive muscular dystrophy with adhalin (50 kDa dystrophin-associated glycoprotein) deficiency. CR Acad Sci Paris 1994, 317:70-76.
56. Piccolo F, Roberds SL, Jeanpierre M, Letureq F, Azibi K, Beldjord C, Carrie A, • Rrecan D, Chaouch M, Reghis A el al.: Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity. Nature Genet 1995, 10:243-245. A comprehensive account of progress achieved in this field.
57. Fardeau M, Matsumara K, Tome MS, Collin H, Leturco F, Kaplan JC, Campbell KP: Deficiency of the 50 kDa dystrophin associated glycoprotein (adhalin) in severe autosomal recessive muscular dystrophies in children native from European countries. CR Acad Sci Paris 1993, 316:799-804.
58. Kawai H, Inui T, Mitsui T, Campbell KP, Shimizu T, Matsumura K: Complete • deficiency of adhalin (50 kDA DAG) in skeletal muscle of malignant limb girdle muscular dystrophy [In Japanese]. Rinsho Shinkeigaku 1995, 35: 184-189. The first report of adhalinopathy in the Eastern hemispheres.
59. Hayashi YK, Mizuno Y, Yoshida M, Nonaka I, Ozawa E, Arahata K: The frequency of patients with 50 kd dystrophin associated grycoprotein in Japan: immunocytochemical analysis of 50DAG, 43 DAG dystrophin, and utrophin. Neurology 1995, 45:551-554.
60. Lim LE, Duclos F, Broux O, Bourg N, Sunada Y, Allamand V, Meyer J, Richard I, Moomaw C, Slaughter C et al.: β-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nature Genet 1995, 11:257-265.
61. Bonnemann CG, Modi R, Noguchi S, Mizuno Y, Yoshida M, Gussoni E, McNally EM, Duggan DJ, Angelini C, Hoffman EP et al.: β-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nature Genet 1995, 11:266-273.
62. Campbell KP: Adhalin gene mutatins and autosomal recessive limbgirdle • muscular dystrophy. Ann Neurol 1995, 38:353-354. Recognition of mutations in the 50 kd dystrophin associated protein (adhalin) as a cause of LGMD.
63. Toda T, Segawa M, Nomura Y, Nonaka I, Masuda K, Ishihara T, Sakai M, Tomita I, Oviguchi Y, Suzuki M: Localization of the gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31-33. Nature Genet 1993, 5:283-286.
64. Toda T, Yoshioka M, Nakahori Y, Kanazawa I, Nakamura Y, Nakagome Y: Genetic identity of Fukuyama type congenital muscular dystrophy and Walker-Warburg Syndrome. Ann Neurol 1995, 37:99-101.
65. Hilaire D, Leclerc A, Faure S, Topaloglu H, Chiannilkulchai N, Guicheney P, Grinas L, Legos P, Philpol J, Evangelista T el al.: Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. Hum Mol Genet 1994, 3:1657-1661.
66. Tome FMS, Evagelista T, Leclerc A, Sunada Y, Manole E, Estournet B, Barois A, Campbell KP, Fardeau M: Congenital muscular dystrophy with merosin deficiency. CR Acad Sci Paris 1994, 317:351-357.
67. Hebling-Leclerc A, Zhang X, Topaloglu H, Cruaud C, Tesson F, Weissenbach J, Tome FMS, Schwartz K, Fardeau M, Tryggvason K, Guicheney P: Mutations in the laminin α2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nature Genet 1995, 11:216-218.
68. Sewry CA, Philpot J, Sorokin LM, Wilson LA, Naom I, Goodwin F, D'Alessandro M, Dubowitz V, Muntoni F: Diagnosis of merosin (laminin-2) deficient congenital muscular dystrophy by skin biopsy. Lancet 1996, 347:582-584.
69. Bione S, Maestrini E, Rivella S, Mancini M, Regis S, Romeo G, Toniolo D: Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nature Genet 1994, 8:323-327.
70. Nagano A, Koga R, Ogawa M, Kurano Y, Kawada J, Okada R, Hayashi YK, Tsukahara T, Arahata K Emerin deficiency at the nuclear membrane in patients with Emery-Dreifus muscular dystrophy. Nature Genet 1996, 12:254-259.
71. Behlem J, van Wijngaarden GK: Benign myopathy, with autosomal dominant inheritance - a report on three pedigrees. Brain 1976, 99:91-100.
72. Jobsis GJ, Boilhuis PA, Boers JM, Baas F, Wolterman RA, Hensels GW, Devisser M: Genetic localization of Bethlem myopathy. Neurology 1996, 46:779-782.
73. de Visser M, Jobsis GJ, Barth PG, Boers JM: Bethlem myopathy: clinical aspects [Abstract]. Neuromusc Disord 1996, 6:S14.